Coming Soon

340B Pharmacy Partnerships

Building compliant, community-centered 340B partnerships.
Where we stand today

Preparing for the federal 340B Drug Pricing Program

Ropheka Pharmacy is preparing to expand into the federal 340B Drug Pricing Program through strategic partnerships with eligible covered entities.

While we are not currently contracted under the 340B program, we are intentionally building the operational, compliance, and reporting infrastructure required to support high-quality, audit-ready 340B pharmacy services. Our approach prioritizes transparency, patient care, and long-term sustainability.

We are taking a phased and intentional approach to ensure that every aspect of our future 340B offering meets regulatory standards and aligns with our mission of excellence in care.

Program background

About the 340B Drug Pricing Program

The 340B Drug Pricing Program enables eligible healthcare organizations — known as covered entities — to purchase outpatient medications at reduced prices.

These savings allow organizations to stretch limited resources and reinvest in expanded services, improved access to care, and better patient outcomes.

Our vision

Our Vision for 340B at Ropheka Pharmacy

Our goal is to partner with covered entities to deliver a 340B program that is:

Fully compliant and audit-ready

Operational and reporting infrastructure built to withstand HRSA and manufacturer audits from day one.

Transparent and accountable

Clear reporting and open operations, so covered entities always know how their program is performing.

Patient-focused

An emphasis on access and continuity of care for the patients each covered entity serves.

Community-based

Led by a trusted independent pharmacy partner rooted in the communities we dispense to.
Who this page is for

We welcome early conversations

We welcome early conversations with organizations that are:

What to expect after submission
Get in touch

Interested in a Future 340B Partnership?

Covered entities exploring contract pharmacy options are welcome to contact us directly.